We are live on
!
Find out more
TFCM
Taylor Frigon Capital Management Portfolio holdings
AUM
$214M
1-Year Est. Return
47.29%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+47.29%
3 Year Est. Return
+130.72%
5 Year Est. Return
+143.46%
10 Year Est. Return
–
AUM
$192M
AUM Growth
-$280K
(-0.15%)
Cap. Flow
+$2.91M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
27.25%
Holding
89
New
3
Increased
60
Reduced
22
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procept Biorobotics
PRCT
|
+$3.22M |
| 2 |
VLD
Velo3D, Inc.
VLD
|
+$1.51M |
| 3 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$1.46M |
| 4 |
FMC
FMC
|
+$1.35M |
| 5 |
Compugen
CGEN
|
+$1.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Codexis
CDXS
|
+$2.02M |
| 2 |
NovoCure
NVCR
|
+$1.87M |
| 3 |
Glaukos
GKOS
|
+$1.44M |
| 4 |
Comcast
CMCSA
|
+$1.26M |
| 5 |
AYX
Alteryx Inc
AYX
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.08% |
| 2 | Healthcare | 18.63% |
| 3 | Industrials | 11.45% |
| 4 | Financials | 7.97% |
| 5 | Consumer Discretionary | 6.11% |
Similar funds
SIA
IH
CMBA
TSS
RC
PFA
VPWA
IAM
Taylor Frigon Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Taylor Frigon Capital Management held 89 positions worth $192M, down 0.15% from $192M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Taylor Frigon Capital Management's Q3 2022 filing shows 3 new, 60 increased, 22 reduced and 3 closed positions. Its largest new stake was Procept Biorobotics: 80,619 shares worth $3.34M. The largest sale was Codexis, an estimated $2.02M.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.
- Taylor Frigon Capital Management's largest Q3 2022 buy was Procept Biorobotics: 80,619 shares worth $3.34M.
- Taylor Frigon Capital Management added most to Velo3D, Inc. in Q3 2022, an estimated $1.51M increase.
- Taylor Frigon Capital Management's biggest Q3 2022 reduction was NovoCure, cutting an estimated $1.87M.
- Taylor Frigon Capital Management fully exited Codexis in Q3 2022, selling an estimated $2.02M.
- Taylor Frigon Capital Management's ten largest holdings make up 27% of its $192M portfolio in Q3 2022.
- Taylor Frigon Capital Management opened 3 new positions and closed 3 in Q3 2022.
- Taylor Frigon Capital Management's portfolio value fell 0.15% quarter-over-quarter to $192M.
Based on Taylor Frigon Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.